Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cyclogyl
1. 512-15-2
2. Cyclopentylate
3. Cyclogyl
4. 2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate
5. Ciclopentolato
6. Cyclopentolatum
7. Cyclopentolatum [inn-latin]
8. Ciclopentolato [inn-spanish]
9. Mydrilate
10. Bell Pentolate
11. Cyclopentolate (inn)
12. 2-(dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate
13. I76f4shp7j
14. 1-hydroxy-alpha-phenylcyclopentaneacetic Acid 2-(dimethylamino)ethyl Ester
15. Benzeneacetic Acid, .alpha.-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl Ester
16. Chebi:4024
17. 2-(dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate
18. Alpha-(1-hydroxycyclopentyl)benzeneacetic Acid 2-(dimethylamino)ethyl Ester
19. Beta-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate
20. Tsiklopentolat;cyclogyl;dl-cyclopentolate
21. Cyclopentoiate
22. Diopentolate
23. Beta-(dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetate
24. 2-phenyl-2-(1-hydroxycyclopentyl)ethanoic Acid Beta-(dimethylamino)ethyl Ester
25. Cyclopentolate [inn]
26. Cyclopentolate [inn:ban]
27. (+-)-cyclopentolate
28. Bell Pentolate (tn)
29. Einecs 208-136-4
30. Unii-i76f4shp7j
31. Cyclo-pentolatum
32. Benzeneacetic Acid, Alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl Ester
33. Cyclogyl (salt/mix)
34. Mydrilate (salt/mix)
35. Spectrum_000856
36. (+/-)-cyclopentolate
37. 2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetat
38. Prestwick0_001095
39. Prestwick1_001095
40. Prestwick2_001095
41. Prestwick3_001095
42. Spectrum2_001122
43. Spectrum3_000369
44. Spectrum4_000303
45. Spectrum5_000793
46. Cyclopentolate [mi]
47. Bspbio_001170
48. Bspbio_002097
49. Kbiogr_000886
50. Kbioss_001336
51. Cyclopentolate [vandf]
52. Divk1c_000610
53. Schembl132500
54. Spbio_000983
55. Spbio_003055
56. Bpbio1_001288
57. Gtpl7153
58. Cyclopentolate [who-dd]
59. Chembl1201338
60. Dtxsid3048528
61. Bdbm82375
62. Kbio1_000610
63. Kbio2_001336
64. Kbio2_003904
65. Kbio2_006472
66. Kbio3_001317
67. Ninds_000610
68. Bcp21334
69. Nsc_2905
70. Mfcd00599448
71. Stl430452
72. Akos015962137
73. Db00979
74. Idi1_000610
75. Cyclopentolatum; Cyclogyl; Cyclopentylate
76. Ncgc00018213-02
77. Ac-15991
78. As-16057
79. Cas_512-15-2
80. Sbi-0051324.p003
81. Ab00053445
82. Ft-0624265
83. C06932
84. D07759
85. H10434
86. Ab00053445_12
87. A913427
88. L000802
89. Q867332
90. Brd-a77291778-003-05-5
91. Brd-a77291778-003-15-4
92. .beta.-(dimethylamino)ethyl (1-hydroxycyclopentyl)phenylacetate
93. 2-(dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate #
94. 2-dimethylaminoethyl 1-hydroxy-.alpha.-phenylcyclopentaneacetate
95. (+)-alpha-(1-hydroxycyclopentyl)benzeneacetic Acid 2-(dimethylamino)ethyl Ester
96. (?)-alpha-(1-hydroxycyclopentyl)benzeneacetic Acid 2-(dimethylamino)ethyl Ester
97. 1-hydroxy-.alpha.-phenylcyclopentaneacetic Acid, 2-(dimethylamino)ethyl Ester
98. 2-(dimethylamino)ethyl (+/-)-1-hydroxy-.alpha.-phenylcyclopentaneacetate
99. Cyclopentaneacetic Acid, 1-hydroxy-.alpha.-phenyl-, 2-(dimethylamino)ethyl Ester
| Molecular Weight | 291.4 g/mol |
|---|---|
| Molecular Formula | C17H25NO3 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 291.18344366 g/mol |
| Monoisotopic Mass | 291.18344366 g/mol |
| Topological Polar Surface Area | 49.8 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 331 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Cyclogyl |
| PubMed Health | Atropine |
| Drug Classes | Anesthetic Adjunct, Cholinergic Antagonist, Gastrointestinal Agent, Nerve Gas Antidote, Urinary Antispasmodic |
| Drug Label | CYCLOGYL (cyclopentolate hydrochloride ophthalmic solution, USP) is an anticholinergic prepared as a sterile, borate buffered, solution for topical ocular use. It is supplied in three strengths. The active ingredient is represented by the structura... |
| Active Ingredient | Cyclopentolate hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 0.5%; 1%; 2% |
| Market Status | Prescription |
| Company | Alcon; Alcon Labs |
| 2 of 4 | |
|---|---|
| Drug Name | Pentolair |
| Active Ingredient | Cyclopentolate hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 1% |
| Market Status | Prescription |
| Company | Bausch And Lomb |
| 3 of 4 | |
|---|---|
| Drug Name | Cyclogyl |
| PubMed Health | Atropine |
| Drug Classes | Anesthetic Adjunct, Cholinergic Antagonist, Gastrointestinal Agent, Nerve Gas Antidote, Urinary Antispasmodic |
| Drug Label | CYCLOGYL (cyclopentolate hydrochloride ophthalmic solution, USP) is an anticholinergic prepared as a sterile, borate buffered, solution for topical ocular use. It is supplied in three strengths. The active ingredient is represented by the structura... |
| Active Ingredient | Cyclopentolate hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 0.5%; 1%; 2% |
| Market Status | Prescription |
| Company | Alcon; Alcon Labs |
| 4 of 4 | |
|---|---|
| Drug Name | Pentolair |
| Active Ingredient | Cyclopentolate hydrochloride |
| Dosage Form | Solution/drops |
| Route | Ophthalmic |
| Strength | 1% |
| Market Status | Prescription |
| Company | Bausch And Lomb |
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
S01FA04
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
S - Sensory organs
S01 - Ophthalmologicals
S01F - Mydriatics and cycloplegics
S01FA - Anticholinergics
S01FA04 - Cyclopentolate
Absorption
Absorbed following ophthalmic administration.
By blocking muscarinic receptors, cyclopentolate produces dilatation of the pupil (mydriasis) and prevents the eye from accommodating for near vision (cycloplegia).
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Italy
Brand Name : Ciclolux
Dosage Form :
Dosage Strength : Coll 3 Ml 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Cyclogyl
Dosage Form : Eye Drop
Dosage Strength : 1%
Packaging :
Approval Date : 24/11/1959
Application Number : 19591124000024
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Cyclogyl
Dosage Form : Eye Drop
Dosage Strength : 0.005
Packaging :
Approval Date : 23/08/1968
Application Number : 32634
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Cyclogyl
Dosage Form : Eye Drop
Dosage Strength : 0.01
Packaging :
Approval Date : 23/08/1968
Application Number : 32634
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Brand Name : Cyclopentolat Minims
Dosage Form : Eye drops, resolution
Dosage Strength : 10 mg/ml
Packaging : Endosebeholder
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Cyclopentolate Bausch & Lomb
Dosage Form : Eye Drop
Dosage Strength : 10mg/ml
Packaging :
Approval Date : 11/11/1983
Application Number : 19831111000027
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorised
Registration Country : Malta
Brand Name : Minims Cyclopentolate Hydrochloride
Dosage Form : Eye Drop Solution
Dosage Strength : 1%W/V
Packaging :
Approval Date : 2005-10-04
Application Number :
Regulatory Info : Authorised
Registration Country : Malta
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Cyclogyl
Dosage Form : Eye Drop
Dosage Strength : 1%
Packaging :
Approval Date : 18/04/2018
Application Number : 20170905000024
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Cyclogyl
Dosage Form : Eye Drop
Dosage Strength : 1%
Packaging :
Approval Date : 13/09/2017
Application Number : 20161025000018
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Cyclogyl
Dosage Form : Eye Drop
Dosage Strength : 1%
Packaging :
Approval Date : 13/09/2017
Application Number : 20161025000025
Regulatory Info : Deregistered
Registration Country : Sweden
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Cyclogyl 1%
Dosage Form : OPD
Dosage Strength : 10mg/ml
Packaging : 15X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Cyclomydril
Dosage Form : OPD
Dosage Strength : 2mg/ml
Packaging : 5X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info :
Registration Country : Argentina
Brand Name :
Dosage Form : Ophthalmic Solution
Dosage Strength : 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Argentina
Packaging :
Regulatory Info :
Dosage : Ophthalmic Solution
Dosage Strength : 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : Argentina
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Eye Drops
Dosage Strength : 10MG
Packaging : 5 ml HDPE Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 5 ml HDPE Bottle
Regulatory Info :
Dosage : Eye Drops
Dosage Strength : 10MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
12
PharmaCompass offers a list of Cyclopentolate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyclopentolate manufacturer or Cyclopentolate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyclopentolate manufacturer or Cyclopentolate supplier.
PharmaCompass also assists you with knowing the Cyclopentolate API Price utilized in the formulation of products. Cyclopentolate API Price is not always fixed or binding as the Cyclopentolate Price is obtained through a variety of data sources. The Cyclopentolate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyclopentolate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyclopentolate, including repackagers and relabelers. The FDA regulates Cyclopentolate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyclopentolate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyclopentolate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyclopentolate supplier is an individual or a company that provides Cyclopentolate active pharmaceutical ingredient (API) or Cyclopentolate finished formulations upon request. The Cyclopentolate suppliers may include Cyclopentolate API manufacturers, exporters, distributors and traders.
click here to find a list of Cyclopentolate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cyclopentolate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyclopentolate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyclopentolate GMP manufacturer or Cyclopentolate GMP API supplier for your needs.
A Cyclopentolate CoA (Certificate of Analysis) is a formal document that attests to Cyclopentolate's compliance with Cyclopentolate specifications and serves as a tool for batch-level quality control.
Cyclopentolate CoA mostly includes findings from lab analyses of a specific batch. For each Cyclopentolate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyclopentolate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyclopentolate EP), Cyclopentolate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyclopentolate USP).
